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Abstract: 
Background: The General Anesthesia compared to Spinal anesthesia (GAS) study is a 
prospective randomized, controlled, multi-site, trial designed to assess the influence of general 
anesthesia (GA) on neurodevelopment at five years of age.   A secondary aim obtained from the 
blood pressure data of the GAS trial is to compare rates of intraoperative hypotension after 
anesthesia and to identify risk factors for intraoperative hypotension.  
 
Methods: 722 infants ≤ 60 weeks postmenstrual age undergoing inguinal herniorrhaphy were 
randomized to either bupivacaine RA or sevoflurane GA. Exclusion criteria included risk factors 
for adverse neurodevelopmental outcome and infants born < 26 weeks’ gestation. Moderate 
hypotension was defined as mean arterial pressure (MAP) measurement of < 35 mm Hg.  Any 
hypotension was defined as mean arterial pressure (MAP) of <45 mm Hg. Epochs were defined 
as a 5 minute measurement periods.  The primary outcome was any measured hypotension <35 
mm Hg from start of anesthesia to leaving the operating room.  This analysis is reported 
primarily as intention to treat (ITT) and secondarily as per protocol (APP).  
 
Results: The relative risk of general anesthesia compared with regional anesthesia predicting any 
measured hypotension<35 mm Hg from the start of anesthesia to leaving the operating room was 
2.8 (CI 2.0, 4.1, p value <0.001) by ITT analysis and 4.5 (CI 2.7,7.4, p value <0.001) by APP 
analysis(?). 
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In the GA group 87% and 49% and in the RA group 41% and 16% exhibited any or moderate 
hypotension by ITT, respectively.  In multivariable modeling, group assignment (GA vs. RA), 
weight at the time of surgery and minimal intraoperative temperature were risk factors for 
hypotension.   Interventions for hypotension occurred more commonly in the GA group 
compared with the RA group (Relative Risk 2.8, 95% CI:1.7,4.4 by ITT).  
 
Conclusions: RA reduces the incidence of hypotension and chance of intervention to treat it 
compared with sevoflurane anesthesia in young infants undergoing inguinal hernia repair.  
 
Keywords: Anesthesia, General; Anesthesia, Spinal; Blood Pressure; Infant 
 
 
 
 
 
 
 
Introduction: 
It is estimated that over 6 million general anesthetics are administered to young children 
worldwide annually.(1,2)  Several studies have demonstrated an association between surgery in 
infancy and increased risk of poor neurobehavioral outcome, although the reason for this 
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association is unclear.(3-5)  Since many general anesthetics cause neurotoxicity in young 
animals, there is concern that general anesthetics maybe neurotoxic to infants.(6-8)   Apart from 
neurotoxicity, there may be other modifiable peri-operative factors which impact on long term 
neurocognitive outcome, among them hypotension.(9)    
 
The General Anesthesia compared to Spinal anesthesia (GAS) study, a prospective randomized 
equivalence trial,  which was designed to determine whether GA and RA have similar long-term 
effects on the developing brain.{Davidson, 2016 #3031}In this study 722 infants undergoing 
inguinal herniorrhaphy were randomized to regional anesthesia (RA) or general anesthesia (GA).  
The apnea, interim 2 year neurocognitive and summary blood pressure data have been recently 
published elsewhere.  The hypothesis of this study is that moderate hypotension is more common 
in infants undergoing general anesthesia compared to infants undergoing regional anesthesia as 
measured by the incidences of moderate hypotension.  Secondary aims were to compare duration 
of hypotension and the incidence of interventions to treat it, and identify factors associated with 
hypotension.  
 
 
 
 
Methods: 
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This manuscript adheres to the applicable Equator guidelines.  The GAS study is registered in 
Australia and New Zealand at ANZCTR: ID# ACTRN12606000441516 first registered on 16th 
October 2006, Principal Investigators Andrew Davidson, Mary Ellen McCann and Neil Morton; 
in the USA at ClinicalTrials.gov: ID#: NCT00756600 first registered on 18th September 2008, 
Principal Investigators Andrew Davidson, Mary Ellen McCann and Neil Morton; and in UK at 
UK Clinical Research Network (UKCRN) ID#: 6635 (ISRCTN ID#: 12437565; MREC No: 
07/S0709/20) Principal Investigator Neil Morton. The protocol for the GAS study has been 
previously published by The Lancet.13  
 
 
Study participants 
After institutional review board approval from each site and written informed consent from 
parents or guardians, infants were enrolled. (Table 1) Recruitment began in 2007 and ended in 
2013.  Eligibility criteria included infants up to 60 weeks’ postmenstrual age (PMA) undergoing 
inguinal herniorrhaphy (with or without circumcision) born at greater than 26 weeks’ gestation. 
Exclusion criteria included  contraindications for either anesthetic technique,  history of  heart 
disease requiring surgery or pharmacotherapy, mechanical ventilation immediately prior to 
surgery, known chromosomal or congenital abnormalities known to affect neurodevelopment, 
previous exposure to volatile GA or benzodiazepines as a neonate or in the third trimester in 
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utero,  known neurologic injury such as cystic peri-ventricular leukomalacia or grade three or 
four intra-ventricular hemorrhage, and social or geographic factor or language barriers that made  
follow up difficult.  Eligible infants were identified from operating room schedules and pre-
admission clinics.    
 
Randomization and blinding 
A 24-hour web-based randomization was managed by The Data Management & Analysis Centre, 
Department of Public Health, University of Adelaide, South Australia. Children were 
randomized with a 1:1 allocation ratio to either RA or GA by random permuted blocks of two or 
four and stratified by site and gestational age at birth: 26 to 29 weeks and 6 days, 30 to 36 weeks 
and 6 days, and 37 weeks and more.  
 
Procedures 
Patients in the RA arm received regional anesthesia: either spinal, spinal with caudal, spinal with 
ilioinguinal nerve block, or caudal block. The anesthetic used was bupivacaine or 
levobupivacaine.  Some patients received caudal chloroprocaine intra-operatively to prolong the 
block. In the RA arm, any sedation or GA given was considered a protocol violation.  Oral 
sucrose drops were permitted in the RA arm and acetaminophen (paracetamol) in both arms. 
Those in the GA arm received sevoflurane in air/oxygen for induction and maintenance along 
with neural blockade via caudal or ilioinguinal block with bupivacaine or levobupivacaine. 
Airway support and use of neuromuscular blocking agents was not standardized. No opioids or 
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nitrous oxide were allowed intra-operatively. Blood pressure, heart rate, oxygen saturation, end-
tidal CO2 and temperature were recorded every 5 minutes intra-operatively.  Because there was 
no airway management standardization within this study, end tidal CO2 measurements were 
considered unreliable.  These measurements were recorded on the Case Report Forms by a 
research assistant and in the anesthesia record. A blood glucose measurement was obtained 
perioperatively.   
 
The pre-specified primary outcome for this analysis was at least one epoch of observed moderate 
hypotension. Secondary outcomes include observation of at least one epoch of observed any 
hypotension; at least three epochs of moderate hypotension, at least three epochs of any 
hypotension and average intraoperative MAP as well as interventions done for blood pressures 
less than 80% of baseline.  Moderate hypotension and any hypotension was defined as single or 
multiple measures of MAP of <35 mm Hg and MAP of <45 mm Hg, respectively.  NIRS  and 
Doppler evidence demonstrates that cerebral blood flow decreases at MAPs <45 mm Hg and 
cerebral oxygenation decreases at MAPs <35 mm Hg in infants <6 months undergoing 
sevoflurane anesthesia.(10) An epoch was defined as a single intraoperative measurement 
representing a 5 minute period. Multiple measures within a 5 minute period were averaged. 
Mean arterial pressures were calculated from the formula ((systolic BP) +2(diastolic BP))/3. Cuff 
position (calf vs arm) was not adjusted for because there is less than a 1 mm Hg difference 
between calf and arm pressures in infants less than 3 months.(11,12)  Cuff size was determined 
by choice of a cuff width that was between 2/3 the length of either the humerus, femur or tibia 
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depending on the limb. Baseline blood pressure measurements were the first blood pressure 
measured in the operating room. Intraoperative and PACU interventions for blood pressure 
greater than 20% below baseline included lactated Ringer’s bolus of 20 milliliters/kilogram and 
vasoactive medications at the discretion of the anesthesiologist.   
 
Prolonged hypotension was defined as 3 or more consecutive epochs of MAP <35 mm Hg.  
Any hypotension and moderate hypotension rates were analyzed in three time periods: anesthesia 
time: time from the start of the anesthesia to time of leaving the operating room (primary 
analysis); pre-incision time: time from the start of anesthesia to incision and   
 surgical time: time between knife to skin and last stitch. The level of intervention for 
intraoperative hypotension was also noted.   A significant intervention was defined a-priori as a 
fluid bolus or the administration of a vasoactive substance.  
 
 
Statistical Analysis: 
 
Analysis populations 
The primary analysis is reported as intention to treat (ITT) excluding participants who withdrew 
consent or were randomized after surgery. A secondary analysis was performed as per-protocol 
(APP), which excludes cases where surgery was cancelled, and in the RA arm, any child who 
received any sevoflurane or sedative medication.  
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Data analysis 
For occurrence of moderate and any hypotension, a comparison between GA and RA groups is 
presented as a relative risk (RR) estimated using the generalised estimating equation (GEE) 
approach, assuming binomially distributed outcome data, and applying a log link function and 
robust standard errors in Stata 13 (Stata Corp LP., USA).  A fixed effect was fitted for each 
group and gestational age (treated as a continuous outcome) and an exchangeable correlation was 
assumed between observations within the same site. It is noted in the results where the GEE 
approach did not converge, and an alternative, more conservative method was applied. 
 
For average MAP, a comparison between GA and RA groups is presented as a difference in 
means as estimated from a 3-level random intercept model, where site is the top level, individual 
is the second level and observation within individual is the third level, using xtmixed with 
maximum likelihood estimation in Stata 13 (Stata Corp LP., USA). A random intercept is fit to 
each randomization site and individual, and a fixed effect is fit for each group and gestational 
age. The residual errors within each individual were assumed to have an autoregressive structure 
of order 4, to account for the expected autocorrelation between successive blood pressure 
measurements. An order of 4 was chosen by performing a likelihood ratio test between models 
fit with successive orders of autogression for observations in the anesthesia time period, and 
selecting the highest order where p<0.05. All estimates are presented with 95% confidence 
intervals (CIs) and two-sided p-values    As a further secondary analysis we aimed to identify 
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risk factors for prolonged hypotension (3 or more consecutive epochs <35 mm Hg).   Prolonged 
hypotension was chosen instead of any hypotension because the outcomes are likely to be more 
severe.    . The following risk factors for prolonged hypotension (3 or more consecutive epochs 
<35 mm Hg) were identified a-priori: chronological age, gender, weight at time of surgery, 
postmenstrual age at time of surgery, gestational age at birth, preoperative fasting time, 
preincisional times, intraoperative temperature (mean and  minimum values) and duration of 
surgery.  These risk factors were chosen by previous research and consensus by and clinical 
expertise of the authors.     
 
To assess the strength of association of each risk factor with prolonged hypotension we present 
estimates from: a tri-variable model as described in Data Analysis, including allocated study 
group and gestational age in addition to the risk factor of interest; and a full multivariable model 
containing all risk factors of interest. Prior to constructing the full multivariable model we 
assessed the set of risk factors for multicollinearity by visual inspection of twoway scatterplots 
and by calculating the variance inflation factors. We determined that only one factor in the 
following sets of factors could be estimated in the full model: mean intraoperative temperature 
and minimum intraoperative temperature; and weight at surgery, PMA at surgery and 
chronological age at surgery. We selected the factor with the strongest tri-variable association for 
the full model. 
  
 
16 
 
 
Sample size considerations  
The sample size for the GAS study was based on the 5 year neurodevelopmental outcome.(13) 
In line with CONSORT recommendations, post-hoc power calculations were not done and 
instead results are presented with confidence intervals, which capture the uncertainty in our 
findings that reflect the sample size.  
For our sample size of 709, the observed reduction in moderate hypotension from 49% to 16% in 
the GA and RA arms respectively can be estimated with a 95% confidence interval of 2.4 to 4.1 
for relative risk, using an unadjusted two-sample χ2 proportions test. The confidence intervals 
presented in the Results differ because our analysis accounts for the randomization stratification 
factors, and non-independence between observations taken within the same site.  
 
 
 
 
 
Results:  
722 infants were recruited into the trial (see figure 1). For the ITT analysis 355 were in the RA 
arm and 356 in the GA arm (figure 1). Baseline, demographic, anesthetic and surgical data are 
summarized in table 1. There were 394 premature infants and 325 term infants. In the RA arm 70 
patients had a protocol violation involving exposure to sevoflurane or sedation; 10 patients were 
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converted to GA with no block attempted, 23 had a partially successful RA but required sedation 
after incision and 37 had a regional block attempted but were converted to GA before incision. 
Thus for the APP analysis 286 were in the RA arm and 356 in the GA arm. There was no 
hypoglycemia noted in any of the infants.  There were no infants with patent ductus arteriosus or 
other conditions known to alter blood pressure at the time of surgery.  Most of the GA group also 
received concurrent caudal blocks for intra and postoperative analgesia. The mean end-
expiratory sevoflurane concentration measured in the GA group was 2.6 (0.7) %. 
 
MAP was not measured in 14% of epochs in the RA group and 15% in the GA group. The 
missing data occurred mostly at the beginning and end of cases. MAP was missing for 32% of 
the first three epochs after the start of anesthesia in both the GA and RA groups, while in the last 
epoch 33% of GA and 23% of RA cases were missing MAP. Furthermore, in 71% of GA cases 
the first MAP measurement was taken in the 10 minutes after the start of anesthesia, compared to 
51% of RA cases.  The initial baseline MAP for the GA group was 59 mm Hg and 62 mm Hg for 
the RA group by ITT and 61 mm Hg for the RA group by APP. 
 
The relative risk of general anesthesia compared with regional anesthesia predicting any 
measured hypotension<35 mm Hg from the start of anesthesia to leaving the operating room was 
2.8 (CI 2.0, 4.1, p value <0.001) by ITT analysis and 4.5 (CI 2.7,7.4, p value <0.001) by APP 
(Table 4). The percentages of infants in the GA group who exhibited any epochs of any and 
moderate hypotension were 87% and 49% respectively. In the RA group the percentages of 
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infants exhibiting any epochs of any and moderate epochs of hypotension were 41% and 16 % by 
ITT and 34% and 9% by APP, respectively (Table 2). In the GA group, 15% (54 infants) 
experienced 5-9 epochs and 8% (28 infants) experienced 10 or more epochs of moderate 
hypotension with three infants experiencing 15 or more epochs.  In the RA group on APP 
analysis, 8% (22 infants) experienced 1-4 epochs and 2% (5 infants) experienced 5-9 epochs of 
moderate hypotension. These epochs could be consecutive or nonconsecutive.   In the GA group, 
18% (63 infants) had prolonged hypotension (3 or more consecutive measurements<35 mm Hg) 
and in the RA group, 3% (11 infants) by ITT and 0% (1 infant) by APP had prolonged 
hypotension. 
 
There was strong evidence that the mean MAP for the GA group was 10 mm Hg below the mean 
MAP for the RA group in each time period (preincision, surgical time, anesthesia time)  and type 
of analysis (ITT, APP)(Table 3). There was strong evidence for increased risk of any 
hypotension during the anesthesia time period in the GA group in both the ITT population (RR = 
2.1, 95% CI:1.8 – 2.4 , p <0.001 ), and the APP population (RR = 2.5, 95% CI:2.1 - 3.0, p 
<0.001 ), and similarly for moderate hypotension (ITT, RR = 4.8, 95% CI:2.0 - 4.1, p <0.001 ; 
APP, RR = 4.5, 95% CI:2.7 - 7.4, p <0.001) (table 4). 
 
In a multivariable prediction model (N=609, 69 events with complete data) the risk of prolonged 
hypotension was significantly associated with assignment to the GA group (GA RR = 4.63, 95% 
CI:2.23 - 9.66, p <0.001), lower weight at time of surgery (per kg RR =0.56 , 95% CI :0.47 - 
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0.67, p <0.001) and minimum intraoperative temperature (per deg C RR =0.78 , 95% CI:0.65 - 
0.95, p =0.011). There was no evidence for an association between fasting time, surgical time, 
and gender (table 5). We note that mean intraoperative temperature and minimum intraoperative 
temperature; and weight at time of surgery, PMA and chronological age at surgery, were highly 
associated with each other. As a result, the full model can only estimate the association between 
one of these factors with prolonged hypotension. The alternative factors provided almost the 
same strength of association with prolonged hypotension. Each factor may be independently 
important, but the sample size was too small to estimate these associations reliably.   
 
Interventions for hypotension occurred more commonly in the GA group compared with the RA 
group (19.2% vs 7.3% by ITT and 19.2% vs 6.6% by APP).   The most common intervention 
was a fluid bolus, which accounted for 75% or more of the interventions (table 6).  The relative 
risk for GA compared to RA predicting an intervention for hypotension were 2.8 (95% CI:1.7 - 
4.4) by ITT and  2.8 (95% CI:1.7 - 4.9) by APP. 
 
 
 
 
 
 
 
20 
 
 
 
 
 
 
 
 
Discussion: 
In this analysis we found more frequent hypotension in the GA group compared with the RA 
group. The GA group was more likely to demonstrate any and moderate hypotension for both 
single measurements and 3 or more consecutive measurements.   
 
There are many different working definitions of hypotension for awake premature and term 
infants but the acceptable lower limits of blood pressures in neonates and young infants 
undergoing general anesthesia have not been established.(14,15)  Normative data from preterm 
and term infants reveal a steady increase in blood pressure over the first month of life.(12,16-18)    
In term infants, the systolic blood pressure at birth averages 62 mm Hg but by one month of age 
it is >80 mm Hg, representing an increase of almost 30% .(17) The slope for the rise in blood 
pressure for preterm infants is similar.(18)  The rise in calculated MAP over the first month of 
life is approximately 15% from a mean calculated MAP of 52 mm Hg on day 1 to 61 mm Hg on 
day 30.(16,17)     It is also important to note that the blood pressures of infants born prematurely 
are higher than those of term infants at 41 weeks post menstrual age.{Tan, 1988 #182}  The 
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reasons for this are unclear but may have to do with the inflammatory stress that premature 
infants endure while developing. These expected blood pressure differences between term and 
expremature infants highlight the importance of obtaining accurate baseline blood pressures in 
all infants and neonates before anesthesia.   
 
 
It is generally believed that maintaining blood pressure within the limits of cerebral 
autoregulation is optimal for cerebral protection.  Several studies have shown that the lower limit 
of cerebral autoregulation for some infants is indeed fairly close to the definition of MAP 
hypotension using the infant’s age in postmenstrual weeks, although there is also evidence that 
some premature infants are able to demonstrate cerebral autoregulation at a MAP level 
considerably lower than their gestational age in weeks.(19,20) A retrospective analysis of infants 
less than 6 months of age undergoing sevoflurane anesthesia found that the lower limit of 
autoregulation was 45 mm Hg but cerebral oxygenation did not decrease until the MAP was less 
than 35 mm Hg.(10)  
 
Although it is known that hypotension can lead to decreased cerebral perfusion and thus to 
hypoxic ischemic injury to the brain, there are many unknowns to consider in infants undergoing 
general anesthesia.   First the duration of hypotension that puts infants at risk is unknown. In a 
small case series of infants less than 3 months of age undergoing general anesthesia  between 
120 and 180 minutes who did show evidence of perioperative hypoxic ischemic injury, 5 of the 6 
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patients had a mean intraoperative MAP of less than 35 mm Hg for the entire procedure.(21)   It 
is important to note as previously published, no neurocognitive differences were found in the 2 
year interim neurocognitive evaluations between the GA and RA group even though the lowest 
mean single systolic blood pressures noted in the GA group were below the American Heart 
Association guidelines for hypotension in neonates at 55 mm Hg.(22,23)   Also, studies have 
shown that a MAP below 35 mm Hg can lead to decreased cerebral perfusion and cerebral 
oximetry values but there has been no established link between these factors intraoperatively and 
later neurocognitive outcomes.{Rhondali, 2013 #2695}{Rhondali, 2015 #2693}   Risk factors 
for poor neurocognitive outcomes including hypotension and duration of hypotension will be 
analyzed when the final 5 year neurocognitive outcome assessments are completed. 
 
Other risk factors that were associated with moderate prolonged hypotension were weight at the 
time of surgery and minimal temperature recorded during the procedure but these effects sizes 
were small. Weight was a stronger predictor of moderate hypotension than chronological age, 
postmenstrual age or gestational age at birth.  Speculatively, weight might be a proxy for overall 
health as well as age. 
 
Criteria for either the timing or type of intervention for hypotension in young infants have not yet 
been developed.  In our study, a fluid bolus was administered in approximately 75% of 
hypotensive episodes; vasoactive agents were the sole therapy in approximately 15% of 
interventions in the GA group and 21% in the RA group.   
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Study Limitations: 
There are several limitations to this study that warrant discussion. The blood pressure values 
were missing in 14% of our study data, most commonly at the very beginning or end of the case.   
However, sensitivity analysis of these missing values to include additional hypotensive 
measurements for the missing values did not alter the direction of the values. The initial 
measured blood pressures in the RA group occurred later than the initial blood pressure 
measurements in the GA group, which might have introduced a bias.    
 
Another limitation is that location (calf vs arm) and sizes were not standardized as part of the 
protocol.  Pediatric anesthesiologists conventionally use the rule of 2/3rds; the cuff width should 
be 2/3 the length of the underlying bone of the limb measured.  However, this is not the most 
accurate method of sizing blood pressure cuffs.   Measuring the limb circumference at midpoint 
and choosing a blood pressure cuff width that is 40% of this circumference is more 
accurate.(24,25)  This may have introduced some nonsystematic bias into the data since the 
participants are likely to follow the same rule in all patients.  The cuff position among patients in 
the RA group was predominantly the lower limbs. We chose not to adjust for limb placement 
because there is very little difference in limb blood pressure measurements in infants. However, 
leg blood pressures are usually slightly lower than arm blood pressures so any bias in our 
measurements would result in underestimates of the true blood pressure in the regional group. 
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There also was no standardization of the noninvasive blood pressure monitoring systems across 
the sites however both these factors should have been accounted for by randomization.   
 
Another limitation is that the definitions of hypotension in infants undergoing general anesthesia 
are not really developed.  The blood pressures we considered to indicate hypotension may in fact 
have been adequate blood pressures for some or all of the infants who exhibited them.   In 
addition, the risks of hypotension to neurodevelopment are presumably duration dependent and 
“at risk” duration is not known.  We arbitrarily chose 3 or more consecutive epochs of moderate 
hypotension to be important.   
 
In conclusion, a substantial percentage of our patients had calculated mean arterial blood 
pressures less than 35 mm Hg at some point during their anesthetic and the incidence was much 
higher for those who received sevoflurane anesthesia.  The importance and consequences, 
particularly on neurodevelopment, of transient intraoperative hypotension during anesthesia in 
infancy are unknown. The potential for interplay between hypotension and the putative direct 
effects of general anesthetics on neurodevelopment are especially intriguing. Further 
consideration and investigation of this issue is warranted. 
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Table 1. Baseline demographic anesthetic and surgical data.  
 
32 
 
 
Demographics RA arm as intention 
to treat 
N=361 
GA arm as intention 
to treat  
N=358 
RA arm as per 
protocol  
N=286 
Male gender 294 (81.7%) 306 (85.5%) 231 (80.8%) 
Gestational age at birth 
(days) 
248.3 (28.5) 248.6 (27.2) 248.2 (28.7) 
Chronological age at surgery 
(days)* 
70.1 (31.8) 71.0 (31.7) 68.9 (30.9) 
Post menstrual age at surgery 
(days)* 
318.3 (32.6) 319.5 (32) 317.1 (32.0) 
Birth weight (kg) 2.4 (0.9) 2.3 (0.9)  2.3 (0.9) 
Weight at time of surgery 
(kg)* 
4.2 (1.1) 4.3 (1.1) 4.2 91.1) 
Median Apgar at 1 minute  9 (7-9) 9 (7-9) 9 (7-9) 
Median Apgar at 5 minutes 9 (9-10) 9 (9-10) 9 (9-10) 
Ever ventilated with a 
tracheal tube 
47 (13.1%) 45 (12.6%) 37 (12.9%) 
Ever required supplemental 
oxygen 
95 (26.4%) 81 (22.6%) 76 (26.6%) 
Supplemental oxygen 
immediately prior to 
surgery* 
6 (1.7%) 6 (1.7%) 4 (1.4%) 
Electronic monitoring for 
apnea in previous 24 hr 
17 (4.7%) 17 (4.8%) 13 (4.6%) 
Observed apnea previous 24 
hrs  * 
6 (1.7%) 8 (2.2%) 6 (2.1%) 
Fasting time (mins)* 368.2 (146.4) 367.3 (155.1) 370.7 (152.6) 
Pre-operative intravenous 
fluid* 
46 (12.8%) 45 (12.6%) 36 (12.6%) 
Hemoglobin (g.100ml)* 10.3 (2.1) 10.2 (2.0) 10.3 (2.0) 
Baseline oxygen saturation 99 (98-100) 99 (98-100) 99 (98-100) 
Baseline heart rate 152.4 (19.7) 149.9 (16.3) 153.4 (19.9) 
Surgical details*    
Bilateral hernia 
exploration/repair 
162 (45.9%) 161 (45.4%) 127 (44.4%) 
Surgery time: from knife to 
skin to last stitch (mins) 
28.0 (20-38) 28 (20-40) 26.0 (19-35) 
Anesthesia details*    
Anesthesia time: from start 
skin prep for regional or 
induction of GA, to out of 
operating theatre (mins) 
51.0 (40-69) 66 (51.5-84.5) 46.5 (39-61) 
Suxamethonium  0 1 (0.3%) 0 
Non depolarising 20 (5.5%) 125 (34.9%) 0 
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neuromuscular blocker  
Spinal without caudal* 222 (64%) 0 193 (67%)  
Caudal without spinal*  7 (2%) 332 (93.3%) 4 (1%) 
Caudal plus spinal*  117 (34%) 0 89 (31%) 
Ilioinguinal block 3 (0.8%) 16 (4.5%) 2 (0.7%) 
Field block  51 (14.4%) 40 (11.2%) 36 (12.6%) 
Laryngeal mask airway used 7 (2.0%) 60 (16.9%) 0 
Tracheal tube used 40 (11.3%) 281 (79.4%) 0 
Minimum systolic blood 
pressure (mmHg) 
70·7 (15·3) 54·8 (11·7) 73·2 (14·3) 
 
Data presented as mean and standard deviation or median and interquartile range or frequencies 
and percentage of non-missing data. 
 *Note these data refer to all cases where the listed blocks were attempted before the start of 
surgery whether the blocks were effective or not.  GA as per protocol data are not presented as 
only two children in the GA arm had surgery cancelled, so the data is very similar to the 
intention to treat data.   ECG= electrocardiogram; GA= general anesthesia; IQR=interquartile 
range; RA=regional anesthesia. 
 
 
 
 
 
 
 
 
 
Table 2.  
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Intention to Treat 
Outcome by 
frequency 
and by time 
period 
GA (355) RA (354) As per 
Protocol-
RA (286) 
RA to 
Supplemental 
GA/Sedation (23) 
RA to Full GA (37) 
 Number of Epochs of Hypotension <35 mm Hg  
Any Epoch 
< 35 mm Hg 
 
49% (175) 16%(56)  9% (27) 22% (5) 51% (19) 
      
0 51% (180) 84% (298) 91% (259) 78% (18) 49% (18) 
1-4 26% (93) 11% (39) 8% (22) 17% (4) 30% (11) 
5-9 15% (54) 3% (12) 2% (5) 4% (1) 11% (4) 
10-15 7% (25) 1% (3) 0% (0) 0% (0) 5% (2) 
15-19 1% (3) 0% (1) 0% (0) 0% (0) 3% (1) 
20 or > 0% (0) 0% (1) 0% (0) 0% (0) 3% (1) 
      
Number of Epochs of Hypotension <45 mm Hg  
Any Epoch 
< 45 mm Hg 
87% (309) 41%(145) 34% (98) 52% (12) 76% (28) 
      
0 13% (46) 59% (209) 66% (188) 48% (11) 24% (9) 
1-4 20% (72) 22% (79) 23% (65) 17% (4) 24% (9) 
5-9 36% (128) 14% (49) 10% (29) 26% (6) 32% (12) 
10-14 23% (82) 4% (13) 1% (4) 9% (2) 14% (5) 
15-19 6% (20) 1% (2) 0% (0) 0% (0) 0% (0) 
20 or > 2% (7) 1% (2) 0% (0) 0% (0) 5% (2) 
 
Table 2. Outcomes:  Frequency of Hypotensive Events during Anesthesia Time and Blood 
Pressure Estimates by Time Period.   Outcome measures are reported in percentage of total 
patients from each treatment group who exhibited outcome and comparison between RA and GA 
groups are presented as relative risk (RR) with 95% confidence interval (CI) and p-value. RA 
number for ITT is 354 rather than 361 because of missing outcome data; there were 5 cancelled 
surgeries  and 1 withdrawal of consent and 1 RA case where no outcome data was collected.  GA 
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number for ITT is 355 rather than 358 because there were 2 cancelled surgeries and 1 GA case 
with missing hemodynamic data. a Estimate not adjusted for gestational age.     
Table 3.  
Estimates of MAP and HR 
 
Time Period GA Mean 
(SD) 
 RA  
Mean (SD) 
As per 
Protocol-
RA Mean 
(SD) (286) 
 Estimate 
Difference GA-
RA  (ITT) 
95% CI 
Preincision 
MAP 
43.7 (10.5) 55.8 (13.7) 58.2 (13.1) -12.9 
[-14.5, -11.3]* 
Preincision 
HR 
144.6 (15.2) 159.3 (21.8) 160.6 
(22.1) 
-15.4 
[-17.6, -13.2]* 
Surgical 
MAP 
40.9 
 (9.3) 
52.1 (11.6) 54.2 (10.5) -12.2 
[-13.6, -10.8]* 
Surgical HR 138.3 (14.7) 146.8 (19.0) 147.3 
(19.2) 
-8.9 
[-11.1, -6.7]* 
Anesthesia 
MAP  
42.4 (10.2 53.0 (12.2) 55.2 (11.3) -11.3 
[-12.7, -10.0]* 
Anesthesia 
HR 
141.9 (16.3) 150.9 (20.8) 151.6 
(21.1) 
-10.3 
[-12.2, -8.3]* 
 
 
 
Table 3. Time period data presented as mean and standard deviation in mm Hg ; ITT=intention 
to treat, APP= as per protocol,MAP=mean arterial pressure, GA= general anesthesia, 
RA=regional anesthesia, SD=standard deviation. CI = Confidence Interval. *P value <0.001 
Values are unadjusted for gestational age at birth. 
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Table 4.  Relative Risks for Hypotension-related outcomes General Anesthesia compared with 
Regional Anesthesia 
   Intention to Treat  As Per Protocol  
  Outcome Relative 
Risk (95% 
CI) 
P value Relative 
Risk (95% 
CI) 
P value 
Anesthesia 
Time 
AnyHypoten
sion 
MAP<45 mm 
Hg (single  
epoch) a 
2.1 
[1.8,2.4] 
<0.001 2.5 [2.1, 3.0] <0.001 
 
 
MAP<45 mm 
Hg   (triple 
epoch)  
3.5 
[2.7,4.4] 
<0.001 6.8  
[4.5, 10.1] 
 
<0.001 
Moderate 
Hypotension 
MAP<35 mm 
Hg (single  
epoch)  
2.8 [2.0, 
4.1] 
<0.001 4.5 
[2.7, 7.4] 
<0.001 
 
 
MAP<35 mm 
Hg (triple 
epoch)  
5.1  
[2.7,10.1] 
 
<0.001 44.7 
[6.9,290.1 ] 
 
<0.001 
 Any 
Intervention for 
Blood Pressureb 
2.8 
[1.7,4.4] 
<0.001 2.8 
[1.7, 4.9]  
 
<0.001 
Preincision 
Time 
AnyHypoten
sion 
MAP<45 mm 
Hg (single 
epoch) 
2.8 
[2.1, 3.6] 
 
<0.001 3.6 
[2.4, 5.3] 
 
<0.001 
 MAP<45 mm 12.3 <0.001 NA  
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 Hg ( triple 
epoch) 
[4.8,31.4] 
 
 
Moderate 
Hypotension 
MAP<35 mm 
Hg (single 
epoch) 
3.4 
[2.3, 5.0] 
 
<0.001 5.5 [3.1,9.9] 
 
<0.001 
 
 
MAP<35 mm 
Hg (triple 
epoch) 
NA  NA  
Surgical 
Time 
Any 
Hypotension 
MAP<45 mm 
Hg (single 
epoch)a 
2.1 
[1.8, 2.5] 
 
<0.001 2.6 [2.2,3.1] 
 
<0.001 
 
 
MAP<45 mm 
Hg ( triple 
epoch) 
3.0  
[2.3, 4.1] 
 
<0.001 6.6  
[4.4, 9.8] 
 
<0.001 
Moderate 
Hypotension 
MAP<35 mm 
Hg 
3.2  
[2.2, 4.7] 
 
<0.001 5.6  
[3.5, 8.9] 
 
<0.001 
 
 
MAP<35 mm 
Hg (triple 
epoch) 
5.2  
[2.4, 11.1] 
 
<0.001 NA  
 
Estimates of difference between groups presented as relative risk and 95% confidence intervals 
(95% CI). a Estimate not adjusted for gestational age. b Estimate obtained from generalised linear 
model using a log-link assuming outcome data follows a binomial distribution and robust 
standard errors allowing for observations within sites to be clustered. 
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Table 5. Relative risk of 3 consecutive epochs of MAP <35 mm trivariable and multivariable 
model during anesthesia time (time in the room). 
Predictor  Relati
ve 
risk  
tri*  
95% CI P value Relati
ve 
risk  
multi 
N=60
9 
95% 
CI 
P value 
General Anesthesia vs 
Regional Anesthesiaa 
5.62 2.60,12.1 <0.001 4.64  2.23,9.66 <0.001 
Gestational birth age (days)a 0.94 .90,0.98 0.009 1.01 0.97,1.06 0.533 
Weight at surgery (kg) 0.60 0.49,0.72 <0.001 0.56 0.47,0.67 <0.001 
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Log Fasting time (1-2.7, 2.7-
7.4, 7.4-20 hrs) 
0.95 0.65,1.40 0.808 0.94 0.67,1.32 0.711 
Log Surgery time (1-2.7, 2.7-
7.4, 7.4-20 hrs) 
1.27 0.78,2.07 0.331 1.43 0.87,2.36 0.161 
Sex male vs female 1.05 0.59,1.85 0.873 0.96 0.56,1.63 0.870 
Chronologic Age at surgery 
(weeks)b 
0.92 0.86,0.97 0.003 - - - 
PMA at surgery (weeks)b 0.92 0.86,0.97 0.003 - - - 
Mean Temperature (degrees 
Celsius)c 
0.73 0.51,1.03 0.073 - - - 
Minimum Temperature 
(degrees Celsius) 
0.74 0.60,0.90 0.003 0.78 0.65,0.95 0.011 
 
Estimates of difference between groups presented as relative risk and 95% confidence intervals 
(95% CI).  Relative risk tri is the ratio of risk for factor of interest plus randomized anesthetic 
group and gestational age, and includes all non-missing observations.  Relative risk multi is the 
ratio of risk found in a multivariable model. a Bivariable model containing group and gestational 
age as predictors b Factors were strongly associated with weight at surgery and therefore not 
included in full model. c Factor was strongly associated with mean temperature and therefore not 
included in full model. PMA means post menstrual age.  
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Table 6.  Interventions for Hypotension  
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Intervention GA RA (ITT) RA  (APP) 
Bolus only 14.4% (51) 5.6% (20) 5.2% (15) 
Vasoactive only 2.8% (10) 1.4% (5) 1.4% (4) 
Both 2.0% (7) 0.3% (1) 0 (0) 
Total 19.2% (68) 7.3% (26) 
 
6.6% (19) 
 
 
Data presented as percentage of group that was treated.  Parentheses represent actual number of 
patients treated.  ITT=intention to treat, APP= as per protocol. GA=general anesthesia, 
RA=regional anesthesia.    
 
 
 
 
